117 related articles for article (PubMed ID: 1500217)
21. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
[TBL] [Abstract][Full Text] [Related]
22. [Smooth muscle neoplasms of the uterus--a 51 cases study].
Wang M; Xu Y; Zhang T
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):263-5. PubMed ID: 9388867
[TBL] [Abstract][Full Text] [Related]
23. Proliferation characteristics and receptor concentrations in two gynecological carcinomas serially passaged into female nude mice or castrated males.
Vering A; Michel RT; Fortmeyer HP; Stegmüller M
Strahlenther Onkol; 1989 Jul; 165(7):498-9. PubMed ID: 2749478
[No Abstract] [Full Text] [Related]
24. Unusual occurrence of endometrial sarcomas in hybrid mice.
Dawson PJ; Brooks RE; Fieldsteel AH
J Natl Cancer Inst; 1974 Jan; 52(1):207-14. PubMed ID: 4855759
[No Abstract] [Full Text] [Related]
25. Loss of CDKN2A Promoter Methylation Coincides With the Epigenetic Transdifferentiation of Uterine Myosarcomatous Cells.
Roncati L; Barbolini G; Sartori G; Siopis E; Pusiol T; Maiorana A
Int J Gynecol Pathol; 2016 Jul; 35(4):309-15. PubMed ID: 27276112
[TBL] [Abstract][Full Text] [Related]
26. [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors].
Nishida M; Kasahara K; Kaneko M; Iwasaki H; Hayashi K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1103-11. PubMed ID: 4031568
[TBL] [Abstract][Full Text] [Related]
27. [The differential diagnosis between uterine leiomyosarcoma and the special subtypes of leiomyoma].
Zhu XQ; Shi YF; Cheng XD; Wu YZ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1419-21. PubMed ID: 14521746
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclooxygenase-2, c-kit, progesterone and estrogen receptors in uterine smooth muscle tumors: differential diagnosis.
Comunoğlu NU; Durak H; Comunoğlu C; Ekici AI; Ozkan F; Akyildiz EU; Ilvan S; Calay Z; Molinas N
APMIS; 2007 Jun; 115(6):726-35. PubMed ID: 17550381
[TBL] [Abstract][Full Text] [Related]
29. Perivascular Epithelioid Cell Tumors (PEComas) and Smooth Muscle Tumors of the Uterus.
Fadare O
Am J Surg Pathol; 2007 Sep; 31(9):1454-5; author reply 1455-6. PubMed ID: 17721205
[No Abstract] [Full Text] [Related]
30. Cluster analysis of immunohistochemical markers in leiomyosarcoma delineates specific anatomic and gender subgroups.
Carvalho JC; Thomas DG; Lucas DR
Cancer; 2009 Sep; 115(18):4186-95. PubMed ID: 19626649
[TBL] [Abstract][Full Text] [Related]
31. PLAG1-rearrangment in a uterine leiomyosarcoma with myxoid stroma and heterologous differentiation.
Thiryayi SA; Turashvili G; Latta EK; Swanson D; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2021 Oct; 60(10):713-717. PubMed ID: 34184333
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
33. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
34. Biological characteristics of a human uterine leiomyosarcoma cell line,particularly its heterotransplantability and effect on the proliferation of vascular endothelial cells.
Ishiwata I; Ishiwata C; Ishikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):853-8. PubMed ID: 2439619
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
36. Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma.
Baek MH; Park JY; Park Y; Kim KR; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e30. PubMed ID: 29533018
[TBL] [Abstract][Full Text] [Related]
37. Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma.
Horiuchi A; Nikaido T; Taniguchi S; Fujii S
J Natl Cancer Inst; 1999 May; 91(9):790-6. PubMed ID: 10328110
[TBL] [Abstract][Full Text] [Related]
38. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
Rao UN; Finkelstein SD; Jones MW
Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
[TBL] [Abstract][Full Text] [Related]
39. SK-UT-1B, a human tumorigenic diploid cell line.
Chen TR
Cancer Genet Cytogenet; 1988 Jul; 33(1):77-81. PubMed ID: 3383166
[TBL] [Abstract][Full Text] [Related]
40. Atypical uterine leiomyoma: a case report and review of the literature.
Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L
J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
